Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis
- PMID: 16406094
- DOI: 10.1016/j.molimm.2005.11.015
Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis
Abstract
In neuroinflammatory disease complement (C) activation and neuronal apoptosis occur in areas of active pathology. C has a role in clearing apoptotic debris, but is also known to cause necrotic cell death by insertion of the membrane attack complex (MAC). It is therefore unclear whether C is protective or injurious in this context. Here we examine C regulator expression and susceptibility to C activation, lysis and phagocytosis in human neuronal cells undergoing apoptosis in order to model the in vivo situation. We demonstrate that apoptotic neuronal lines lose the C regulators CD46 and CD59. Regulator loss occurred only on cells positive for apoptotic markers, and was caspase dependent. Both CD46 and CD59 were shed from cells, CD46 as a soluble form following MMP cleavage, and CD59 on apoptotic blebs and as a soluble form. Apoptotic cells activated C and were opsonised more readily than control cells; as a consequence they were more readily phagocytosed by macrophages than non-apoptotic cells. Susceptibility to C-mediated lysis was complicated in that early cells were more sensitive while late apoptotic cells were more resistant to killing. MMP inhibition protected against the increased lysis seen in early apoptotic cells, but had no effect on susceptibility of non-apoptotic cells to C-mediated lysis. Our studies suggest that C activation on apoptotic neuronal cells is delicately balanced between enhancing their safe disposal through phagocytosis, and triggering necrosis by C-mediated lysis. The data suggest that therapeutic MMP inhibition, by restricting loss of CD46, may limit neuronal damage in neurological disease.
Similar articles
-
CD59 efficiently protects human NT2-N neurons against complement-mediated damage.Scand J Immunol. 2007 Aug-Sep;66(2-3):345-51. doi: 10.1111/j.1365-3083.2007.01959.x. Scand J Immunol. 2007. PMID: 17635812
-
Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.J Immunol. 1993 Aug 1;151(3):1562-70. J Immunol. 1993. PMID: 7687635
-
Increased sensitivity of early apoptotic cells to complement-mediated lysis.Eur J Immunol. 2004 Nov;34(11):3236-45. doi: 10.1002/eji.200425011. Eur J Immunol. 2004. PMID: 15368275
-
Role of complement and complement regulators in the removal of apoptotic cells.Mol Immunol. 2008 Mar;45(5):1199-207. doi: 10.1016/j.molimm.2007.09.008. Epub 2007 Oct 24. Mol Immunol. 2008. PMID: 17961651 Review.
-
The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain.J Neuropathol Exp Neurol. 2009 Mar;68(3):217-26. doi: 10.1097/NEN.0b013e3181996688. J Neuropathol Exp Neurol. 2009. PMID: 19225414 Review.
Cited by
-
Injury site-specific targeting of complement inhibitors for treating stroke.Immunol Rev. 2016 Nov;274(1):270-280. doi: 10.1111/imr.12470. Immunol Rev. 2016. PMID: 27782326 Free PMC article. Review.
-
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation.BMC Neurosci. 2006 Jul 14;7:55. doi: 10.1186/1471-2202-7-55. BMC Neurosci. 2006. PMID: 16842619 Free PMC article.
-
CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.Neurobiol Aging. 2012 Feb;33(2):422.e11-25. doi: 10.1016/j.neurobiolaging.2010.09.017. Epub 2010 Nov 26. Neurobiol Aging. 2012. PMID: 21112127 Free PMC article.
-
The role of the complement system and the activation fragment C5a in the central nervous system.Neuromolecular Med. 2010 Jun;12(2):179-92. doi: 10.1007/s12017-009-8085-y. Epub 2009 Sep 11. Neuromolecular Med. 2010. PMID: 19763906
-
Role of the complement system in kidney cell death induced by Loxosceles venom Sphingomyelinases D.Arch Toxicol. 2024 May;98(5):1561-1572. doi: 10.1007/s00204-024-03711-8. Epub 2024 Mar 18. Arch Toxicol. 2024. PMID: 38498159
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous